Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000818:Animals; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects* / Q000201:enzymology; D000242:Cyclic AMP / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism; D007545:Isoproterenol / Q000378:metabolism / Q000494:pharmacology; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D011759:Pyrrolidines / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism
D011759:Pyrrolidines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D011954:Receptors, Dopamine; D013134:Spiperone; D011813:Quinuclidinyl Benzilate; D000242:Cyclic AMP; D002795:Choline O-Acetyltransferase; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D005968:Glutamate Decarboxylase; D007545:Isoproterenol; D007608:Kainic Acid; D004298:Dopamine